pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
SPID-961
Childhood Epilepsy
Shackelford Pharma Inc
0 catalysts
Preclinical
SPL-23
Cystic Fibrosis
SpliSense Ltd
0 catalysts
Phase 2
SPL-84
Cystic Fibrosis
SpliSense Ltd
0 catalysts
Phase 2
SPN-821
Major Depressive Disorder
SUPERNUS PHARMACEUTICALS, INC.
← prev
page 158 of 271
next →
131
Pain89
Neurology1
$SUPN
0 catalysts
Preclinical
SPU-16
Multiple Sclerosis
$SILOSilo Pharma, Inc.
0 catalysts
Phase 2
SPVN-06
Retinitis Pigmentosa (Retinitis)
SparingVision SAS
0 catalysts
Phase 1
SPX-303
Solid Tumor
$SHGISparx Holdings Group, Inc.
0 catalysts
Preclinical
SPX-306
Unspecified Cancer
$SHGISparx Holdings Group, Inc.
0 catalysts
Preclinical
SPX-308
Unspecified Cancer
$SHGISparx Holdings Group, Inc.
0 catalysts
Preclinical
SPX-602
Unspecified Cancer
$SHGISparx Holdings Group, Inc.
0 catalysts
Preclinical
SPX-608
Unspecified Cancer
$SHGISparx Holdings Group, Inc.
0 catalysts
Preclinical
SPX-629
Unspecified Cancer
$SHGISparx Holdings Group, Inc.
0 catalysts
Preclinical
SPY-DYS45-55
Duchenne Muscular Dystrophy
MyoGene Bio LLC
0 catalysts
Phase 1
SR-604
Hemophilia A (Factor VIII Deficiency)
Equilibra Bioscience LLC
0 catalysts
Phase 2
SR-750
Trigeminal Neuralgia (Tic Douloureux)
Shanghai SIMR Biotech Co Ltd
0 catalysts
Preclinical
SRC-3KO Treg Adoptive Cell Therapy
Glioblastoma Multiforme (GBM)
CoRegen Inc
0 catalysts
Preclinical
SRC-3KO Treg Allogeneic Cell Therapy
Solid Tumor
CoRegen Inc
0 catalysts
Phase 2
SRD-002
Diastolic Heart Failure (HFpEF)
Sardocor Corp
0 catalysts
Phase 2
SRD-003
Duchenne Muscular Dystrophy
Sardocor Corp
0 catalysts
Phase 1
SRK-439
Obesity
$SRRKScholar Rock Holding Corp
0 catalysts
Phase 1
SRP-3D
Neuropathic Pain (Neuralgia)
South Rampart Pharma LLC
0 catalysts
Phase 2
SRT-100
Genital Warts (Condylomata Acuminata)
G&E Herbal Biotechnology Co., Ltd.
0 catalysts
Phase 2
SRX-246
Huntington Disease
Azevan Pharmaceuticals Inc
0 catalysts
Preclinical
SRX-25
esketamine
Treatment Resistant Depression
Nexalis Therapeutics Ltd
0 catalysts
Phase 2
ST-002
Cushing's Syndrome
SteroTherapeutics LLC
0 catalysts
Preclinical
ST-003
Primary Sclerosing Cholangitis
SteroTherapeutics LLC
0 catalysts
Phase 1
ST-01156
Bile Duct Cancer (Cholangiocarcinoma)
Seed Therapeutics Inc
0 catalysts
Phase 2
ST-266
Necrotizing Enterocolitis
Noveome Biotherapeutics Inc
0 catalysts
Phase 2
ST-503
Neuropathic Pain (Neuralgia)
$SGMOSANGAMO THERAPEUTICS, INC
0 catalysts
Preclinical
ST-7
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)
Phoenicia Biosciences Inc
0 catalysts